AI-designed drug appears to turn back the body's biological clock in early trial
Insilico Medicine's AI-designed drug rentosertib showed reduced predicted biological age in IPF trial blood analysis, published in Nature Biotechnology.
30
- Mentions · 7d0
- Mentions · 30d0
- All mentions2
- First seenSep 4, 2026
- Last mentionedSep 7, 2026
Timeline
2 articles · newest firstAnthropic’s $2 trillion IPO puts powerful external trustees in spotlight
Anthropic's $2 trillion IPO spotlights its external trustee governance, removable only by an 85% shareholder supermajority that may shift post-listing.
58
Appears with
- Insilico Medicineorganization · 1
- Anthropicorganization · 1
- Insilico Medicinevendor · 1
- Eli Lillyvendor · 1
- Eli Lillyorganization · 1
- OpenAIorganization · 1
- Oxfordorganization · 1
- rentosertibproduct · 1
Entities are extracted by the model from each article. First seen , last mentioned . Watching keeps it in this browser only (no account); the watchlist page and dashboard alerts use it.